TP53 and cervical carcinoma: HeLa, a cervix carcinoma cell lineage, was employed as a non-adrenal cell line that did not carry the exon 3 CTNNB1 mutation but which also showed the p.P72R TP53 variation as well as a second intronic TP53 variation (c.97-30C > A/g.11298).